Brief: Alphamab Oncology Posts Loss For Year Rmb412.4 Million
March 29 (Reuters) - Alphamab Oncology:
* LOSS FOR YEAR RMB412.4 MILLION VERSUS LOSS OF HK$427.8
MILLION
* FY REVENUE RMB146 MILLION
Source text for Eikon: ID:nHKS6dC6X1
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)